The Health Care Select Sector SPDR® Fund Newsroom

UnitedHealth's Troubles Get Worse, as 2025 Outlook Suspended and CEO Steps Down

MarketWatchMay 13 11:24 ET

Recent Filing Shows That Rep. Bruce Westerman Sold Over $137K Worth of Apple Stock

BenzingaMay 13 11:00 ET

What Does the Market Think About AbbVie?

BenzingaMay 13 11:00 ET

Benzinga Market Summary: UnitedHealth Suspends FY25 Guidance, Apr. CPI Comes In Softer Than Expected, Trump Middle East On Watch

BenzingaMay 13 10:23 ET

Johnson & Johnson Analyst Ratings

BenzingaMay 13 10:08 ET · Ratings

Biggest Stock Movers Tuesday: COIN, FSLR, UNH, and More

Seeking AlphaMay 13 09:57 ET

Wall Street Climbs As Inflation Cools, Nasdaq 100 Hits 10-Week Highs

BenzingaMay 13 09:46 ET

4 Stocks to Watch on Tuesday: UNH, HOOD, SE and JD

Seeking AlphaMay 13 09:22 ET

Sector Update: Health Care Stocks Mixed Premarket Tuesday

MT NewswiresMay 13 09:16 ET

Leading And Lagging Sectors For May 13, 2025

BenzingaMay 13 09:10 ET

Today's Pre-Market Movers and Top Ratings | UNH, COIN, SE and More

Movers and ShakersMay 13 08:27 ET

3D Systems, Rigetti Computing, UnitedHealth Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

BenzingaMay 13 08:22 ET

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday Ahead of Key Inflation Data

MT NewswiresMay 13 08:15 ET

US Morning News Call | U.S. Cuts China "De Minimis" Tariff to 54%

Moomoo Breakfast USMay 13 07:37 ET

Merck Highlights MK-1084 Data From KANDLELIT-001 in KRAS G12C-Mutated Colorectal And Lung Cancers At ASCO 2025

BenzingaMay 13 06:49 ET

UnitedHealth CEO Andrew Witty Steps Down For Personal Reasons; Chair Stephen Hemsley Takes Over As New Chief, Expects To Reurn To Growth In 2026

BenzingaMay 13 06:34 ET

"Don't sell if prices don't drop!" Trump enforces a mandatory minimum drug price for developed countries, but a lawsuit battle may be "reenacted".

① An executive order signed on the 12th of October, USA time, requires that the payment price of pharmaceuticals in the USA be forcibly anchored to the lowest level of other developed countries within 30 days; ② There is strong opposition within the USA, and industry experts estimate that a legal battle is about to "replay"; ③ As the market-oriented USA begins to wield the big stick of administrative pricing, the underlying rules of the game for Innovative Drugs have quietly been rewritten.

cls.cnMay 12 20:52 ET

Magnificent Seven Gain $700B After US-China Slash Tariffs, Gold Crashes: What's Driving Markets Monday?

BenzingaMay 12 13:20 ET

Amedisys Edges Lower on Report DOJ Initially Rejects Remedy in UnitedHealth

Seeking AlphaMay 12 13:17 ET

AbbVie Unusual Options Activity

BenzingaMay 12 13:02 ET